Fig. 1From: Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysisPooled risk ratio (in log scale) of seroconversion between fractional and standard dose groups of COVID-19 vaccines. Number of seroconversion individuals and sample sizes were shown for the standard and nonstandard groups, respectivelyBack to article page